-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P+kEHwEtbo0UtlrYeKGQsAPh7QNYS5dmAvz+tSYRQLspgBGrEjRcYT2VZmhlQUXB vIaZ69PwoTDsJNra5ra8Jg== 0000950123-10-058931.txt : 20100617 0000950123-10-058931.hdr.sgml : 20100617 20100617161348 ACCESSION NUMBER: 0000950123-10-058931 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100617 DATE AS OF CHANGE: 20100617 EFFECTIVENESS DATE: 20100617 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 10903367 BUSINESS ADDRESS: STREET 1: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 DEFA14A 1 b80593bdefa14a.htm DEFA14A defa14a
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
Information Required in Proxy Statement
Schedule 14A Information
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant      þ
Filed by a Party other than the Registrant      o
Check the appropriate box:
     
o
   Preliminary Proxy Statement
o
   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
o
   Definitive Proxy Statement
þ
   Definitive Additional Materials
o
   Soliciting Material Pursuant to §240.14a-12
HAEMONETICS CORPORATION
 
(Name of Registrant as Specified In Its Charter)
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
     
þ
   No fee required.
 
    
o
   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
             
 
     (1 )   Title of each class of securities to which transaction applies:
 
            
 
 
            
 
     (2 )   Aggregate number of securities to which transaction applies:
 
            
 
 
            
 
     (3 )   Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
 
            
 
 
            
 
     (4 )   Proposed maximum aggregate value of transaction:
 
            
 
 
            
 
     (5 )   Total fee paid:
 
            
 
     
o
   Fee paid previously with preliminary materials.
 
    
o
   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
             
 
     (1 )   Amount Previously Paid:
 
            
 
 
            
 
     (2 )   Form, Schedule or Registration Statement No.:
 
            
 
 
            
 
     (3 )   Filing Party:
 
            
 
 
            
 
     (4 )   Date Filed:

 

Haemonetics Corporation
Important Notice Regarding the Availability of Proxy Materials for the
Stockholder Meeting to Be Held at 10:00 a.m., July 29, 2010.
As part of our efforts to cut unnecessary expenses and conserve the environment, Haemonetics Corporation has elected to provide Internet access to the proxy statement and annual report rather than mailing paper reports. This reduces postage and printing expenses and paper waste. The proxy statement and annual report are available at: http://www.cfpproxy.com/5091
The annual stockholder meeting will be held at 10:00 a.m. on July 29, 2010, at Haemonetics Corporation, 400 Wood Road, Braintree, Massachusetts. The matters to be covered are noted below:
  1.   Election of three directors;
 
  2.   Appointment of Ernst & Young LLP as independent registered public accounting firm for the year ending 2011; and

such other matters as may properly come before the Annual Meeting, or any adjournments thereof.
The Board of Directors is not aware of any other such business. Stockholder of record at the close of business on June 3, 2010 are entitled to vote at the Meeting.
      Your Board of Directors recommends a vote “FOR” each of the above proposals.
This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting.
Shortly, you will receive a proxy card that will reflect the proposals to be voted on at the Annual Meeting. You may vote on-line, by phone, by mail or in person. If you wish to vote on-line or by phone, you will need your Stockholder Control Number that can be found on the bottom right hand corner of this notice. No other personal information will be required in order to vote in this manner.
If you want to receive a paper copy of these documents, you must request one. There is no charge to you for requesting a copy. Please make your request for these reports by July 19, 2010 to facilitate timely delivery, you will need your Stockholder Control Number that can be found in the lower right hand corner of this letter. Then, either:
 
  Ø   Call our toll-free number, (800) 951-2405; or       
 
  Ø   Visit our website at http://www.cfpproxy.com/5091; or       
 
  Ø   Send us an email at fulfillment@rtco.com.
and enter the Stockholder Control Number when prompted or, if you send us an email, enter it in the subject line.
Directions to the meeting are included in the Notice/Proxy Statement.
We ask that you cast your vote promptly. Due to new regulatory changes that will affect your vote on the election of directors, you must vote your proxy for your shares to be represented and voted for the election of directors. Please help save the company additional solicitation costs by voting today.
Thank you for your continued support!
‘Stockholder Control Number’

 -----END PRIVACY-ENHANCED MESSAGE-----